The objective of this proposal is to determine the regulatory role of cAMP phosphodiesterase isozymes (PDEs) in renal cells, namely in cells of inner medullary collecting ducts (IMCD). We will test the hypothesis that cAMP- mediated vasopressin (AVP) effects are modulated by specific PDE isozymes via action of other 2nd messengers (Ca2+, cGMP), and extrarenal hormones, namely glucocorticoids (GCD). In hereditary strain of mice with nephrogenic diabetes insipidus (NDI mice), excessive and/or anomalous cAMP PDE(s) account for complete resistance to AVP, a paradigm of essential role of PDEs in cAMP-mediated action of AVP. Specific objectives include: 1) To identify PDEs which control AVP-dependent cAMP pool(s) in IMCD cells. To define the mechanism by which cAMP generated in response to AVP by acting on PDEs autoregulates the AVP response. To clarify the mechanism by which other hormones (e.g. bradykinin) modulate action of AVP by changing activities of PDEs via other 2nd messengers (cGMP, Ca2+i). 2) To elucidate how glucocorticoids (GCD) regulate the response of IMCD cells to AVP at the step of the PDEs. We will determine which one of PDE isozymes is down-regulated by GCD, and we will delineate the molecular- biochemical mechanism of GCD effect upon PDE in IMCD cells. 3) To determine the mechanism by which PDE isozyme(s) of type-IV, present in IMCD cells of NDI mice, prevents cAMP accumulation and the end-response to AVP. a) We will explore whether higher PDE-IV activity is due to increased quantum of enzyme protein, mRNA, transcription or translation rates in PDE- IV synthesis, or to post-translational modification. Also, whether a mutant PDE-IV with high Vmax or resistance to proteolysis may account for high PDE-IV activity. b) We will test whether stable transfection of cells in vitro by PDE-IV gene will reproduce the resistance to AVP as in NDI mice. In studies on PDE-IV - transfected cells, we will determine, in general, the relationship between cAMP response of IMCD cells to AVP and endogenous activity of PDE- IV isozymes. These studies will be conducted on IMCD cells freshly prepared from rat, rabbit or mouse kidneys, rat IMCD cells grown in primary or continuous in vitro culture, and on established epithelial cell lines.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
General Medicine B Study Section (GMB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Dogan, Soner; Johannsen, Anna C; Grande, Joseph P et al. (2011) Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors. Nutr Cancer 63:389-401
Rogozina, Olga P; Bonorden, Melissa J L; Grande, Joseph P et al. (2009) Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice. Cancer Prev Res (Phila Pa) 2:712-9
Cheng, Jingfei; Zhou, Wei; Warner, Gina M et al. (2009) Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 297:F1055-68
Diaz Encarnacion, Montserrat M; Warner, Gina M; Gray, Catherine E et al. (2008) Signaling pathways modulated by fish oil in salt-sensitive hypertension. Am J Physiol Renal Physiol 294:F1323-35
Dogan, Soner; Hu, Xin; Zhang, Yan et al. (2007) Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res 9:R91
Tracz, Michal J; Juncos, Julio P; Grande, Joseph P et al. (2007) Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol 170:1820-30
Murali, Narayana S; Ackerman, Allan W; Croatt, Anthony J et al. (2007) Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol 292:F837-44
Cheng, Jingfei; Grande, Joseph P (2007) Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med (Maywood) 232:38-51
Cleary, Margot P; Hu, Xin; Grossmann, Michael E et al. (2007) Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response? Exp Biol Med (Maywood) 232:70-80
Cheng, Jingfei; Thompson, Michael A; Walker, Henry J et al. (2006) Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells. Exp Biol Med (Maywood) 231:288-95

Showing the most recent 10 out of 58 publications